quantisnow
FeedTopReportsPricing
⌘K
Live feed
13:48:23·1315d
NEWSRelease
Agile Therapeutics Inc. logo
Dare Bioscience Inc. logo
Endo International plc logo
+3

'West Virginia governor signs abortion ban, making state the second to enact abortion restrictions since Roe overturned.' - Tweet By Zeke Miller

AGRX· Agile Therapeutics Inc.DARE· Dare Bioscience Inc.ENDP· Endo International plcEVFM· Evofem Biosciences Inc.PFE· Pfizer Inc.TEVA· Teva Pharmaceutical Industries Limited
Health Care
Original source

Companies

  • AGRX
    Agile Therapeutics Inc.
    Health Care
  • DARE
    Dare Bioscience Inc.
    Health Care
  • ENDP
    Endo International plc
    Health Care
  • EVFM
    Evofem Biosciences Inc.
    Health Care
  • PFE
    Pfizer Inc.
    Health Care
  • TEVA
    Teva Pharmaceutical Industries Limited
    Health Care

Recent analyst ratings

  • Mar 2PFEUpdateArgus$35.00
  • Feb 25PFEUpdateRBC Capital Mkts$25.00
  • Feb 20PFEUpdateBarclays$25.00
  • Feb 12PFEUpdateDaiwa Securities$27.00
  • Jan 7PFEUpdateUBS$25.00
  • Dec 9TEVAUpdateBarclays$35.00

Related

  • PR1d
    Pfizer Declares Second-Quarter 2026 Dividend
  • SEC1d
    Dare Bioscience Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
  • PR2d
    Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026
  • SEC3d
    Dare Bioscience Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities
  • PR3d
    U.S. FDA Grants Priority Review to sBLA for PADCEV™ + Keytruda® as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility
  • SEC6d
    Dare Bioscience Inc. filed SEC Form 8-K: Leadership Update
  • SEC6d
    SEC Form PRE 14A filed by Dare Bioscience Inc.
  • INSIDER6d
    SEC Form 4 filed by Bourla Albert
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022